Interactive effects of N6AMT1 and As3MT in arsenic biomethylation

Toxicological Sciences

Volumn 146, Issue 2, 2015, Pages 354-362

  Zhang, Hao ^a   Ge, Yichen ^a,c   He, Ping ^a   Chen, Xushen ^a   Carina, Abreu ^a   Qiu, Yulan ^a   Aga, Diana S ^a   Ren, Xuefeng ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Guangdong Prevention and Treatment Center for Occupational Diseases   (China)

Author keywords

Arsenic metabolism; As3MT; N6AMT1

Indexed keywords

ARSENIC; ARSENIC 3 OXIDATION STATE METHYLTRANSFERASE; MESSENGER RNA; METHYLTRANSFERASE; N 6 ADENINE SPECIFIC DNA METHYLTRANSFERASE 1; ORGANOARSENIC DERIVATIVE; UNCLASSIFIED DRUG; AS3MT PROTEIN, HUMAN; N6AMT1 PROTEIN, HUMAN; SITE SPECIFIC DNA METHYLTRANSFERASE (ADENINE SPECIFIC);

ARTICLE; CELL DEATH; CELL LYSATE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; METHYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; MASS SPECTROMETRY; METABOLISM; TRANSFORMED CELL LINE;

ARSENIC; CELL LINE, TRANSFORMED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MASS SPECTROMETRY; METHYLATION; METHYLTRANSFERASES; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC);

EID: 84939617599     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv101     Document Type: Article

References (27)

1. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C.,et al. (1999). Arsenic: Health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107, 593-597.
2. Ahsan, H., Chen, Y., Kibriya, M. G., Slavkovich, V., Parvez, F., Jasmine, F., Gamble, M. V., and Graziano, J. H. (2007). Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16, 1270-1278.
3. Chen, Y., and Ahsan, H. (2004). Cancer burden from arsenic in drinking water in Bangladesh. Am. J. Public Health 94, 741-744.
4. Chen, C. J., Kuo, T. L., and Wu, M. M. (1988). Arsenic and cancers. Lancet 1, 414-415.
5. Chung, C. J., Pu, Y. S., Su, C. T., Chen, H. W., Huang, Y. K., Shiue, H. S., and Hsueh, Y. M. (2010). Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma. Cancer Causes Control 21, 1605-1613.
6. De Chaudhuri, S., Ghosh, P., Sarma, N., Majumdar, P., Sau, T. J., Basu, S., Roychoudhury, S., Ray, K., and Giri, A. K. (2008). Genetic variants associated with arsenic susceptibility:Study of purine nucleoside phosphorylase, arsenic ({thorn}3) methyltransferase, and glutathione S-transferase omega genes. Environ. Health Perspect. 116, 501-505.
7. Drobna, Z., Naranmandura, H., Kubachka, K. M., Edwards, B. C., Herbin-Davis, K., Styblo, M., Le, X. C., Creed, J. T., Maeda, N., Hughes, M. F., et al. (2009). Disruption of the arsenic ({thorn}3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22, 1713-1720.
8. Drobna, Z., Waters, S. B., Devesa, V., Harmon, A. W., Thomas, D. J., and Styblo, M. (2005). Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic ({thorn}3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 207, 147-159.
9. Drobna, Z., Xing, W., Thomas, D. J., and Styblo, M. (2006). shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem. Res. Toxicol. 19, 894-898.
10. Ferrario, D., Croera, C., Brustio, R., Collotta, A., Bowe, G., Vahter, M., and Gribaldo, L. (2008). Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro":Comparison between species and sexes. Toxicology 249, 102-108.
11. Harari, F., Engstrom, K., Concha, G., Colque, G., Vahter, M., and Broberg, K. (2013). N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women. Environ. Health Perspect. 121, 797-803.
12. Kalman, D. A., Dills, R. L., Steinmaus, C., Yunus, M., Khan, A. F., Prodhan, M. M., Yuan, Y., and Smith, A. H. (2014). Occurrence of trivalent monomethyl arsenic and other urinary arsenic species in a highly exposed juvenile population in Bangladesh. J. Expos. Sci. Environ. Epidemiol. 24, 113-120.
13. Kligerman, A. D., Doerr, C. L., Tennant, A. H., Harrington-Brock, K., Allen, J. W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B. C.,et al. (2003). Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic:Induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 42, 192-205.
14. Li, J., Waters, S. B., Drobna, Z., Devesa, V., Styblo, M., and Thomas, D. J. (2005). Arsenic ({thorn}3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. Toxicol. Appl. Pharmacol. 204, 164-169.
15. Lin, G. F., Du, H., Chen, J. G., Lu, H. C., Guo, W. C., Meng, H., Zhang, T. B., Zhang, X. J., Lu, D. R., Golka, K.,et al. (2006). Arsenic-related skin lesions and glutathione S-transferase P1 A1578G (Ile105Val) polymorphism in two ethnic clans exposed to indoor combustion of high arsenic coal in one village. Pharmacogenet. Genomics 16, 863-871.
16. Mosca, R., Pons, T., Ceol, A., Valencia, A., and Aloy, P. (2013). Towards a detailed atlas of protein-protein interactions. Curr. Opin. Struct. Biol. 23, 929-940.
17. Mumford, J. L., Wu, K., Xia, Y., Kwok, R., Yang, Z., Foster, J., and Sanders, W. E. (2007). Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 115, 690-694.
18. Ponten, F., Jirstrom, K., and Uhlen, M. (2008). The Human Protein Atlas-a tool for pathology. J. Pathol. 216, 387-393.
19. Ren, X., Aleshin, M., Jo, W. J., Dills, R., Kalman, D. A., Vulpe, C. D., Smith, M. T., and Zhang, L. (2011). Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ. Health Perspect. 119, 771-777.
20. Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998). Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147, 660-669.
21. Smith, A. H., Marshall, G., Yuan, Y., Ferreccio, C., Liaw, J., von Ehrenstein, O., Steinmaus, C., Bates, M. N., and Selvin, S. (2006). Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114, 1293-1296.
22. Styblo, M., Del Razo, L. M., Vega, L., Germolec, D. R., LeCluyse, E. L., Hamilton, G. A., Reed, W., Wang, C., Cullen, W. R., and Thomas, D. J. (2000). Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74, 289-299.
23. Tapio, S., and Grosche, B. (2006). Arsenic in the aetiology of cancer. Mutat. Res. 612, 215-246.
24. Thomas, D. J., Li, J., Waters, S. B., Xing, W., Adair, B. M., Drobna, Z., Devesa, V., and Styblo, M. (2007). Arsenic ({thorn}3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. 232, 3-13.
25. Tseng, W. P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. (1968). Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463.
26. Valenzuela, O. L., Drobna, Z., Hernandez-Castellanos, E., Sanchez-Pena, L. C., Garcia-Vargas, G. G., Borja-Aburto, V. H., Styblo, M., and Del Razo, L. M. (2009). Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239, 200-207.
27. Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., and Fukushima, S. (2002). Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23, 1387-1397.